24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
02/06/2021
Parc de l’Alba in a WHO publication on the redevelopment of contaminated sites
27/04/2021
Natura Bissé: when architecture reflects the brand identity
08/04/2021
ASTIP, the future hub for advanced research in the Barcelona Synchrotron Park
25/03/2021
4th anniversary of the setting up of Stradivarius headquarter in the Barcelona Synchrotron Park
05/03/2021
T-Systems, a leading IT service provider with a Data Centre in the Barcelona Synchrotron Park
18/02/2021
SENER participates in the Perseverance rover which is landing on Mars today